[go: up one dir, main page]

WO2009064004A1 - シトルリン含有飲料 - Google Patents

シトルリン含有飲料 Download PDF

Info

Publication number
WO2009064004A1
WO2009064004A1 PCT/JP2008/070842 JP2008070842W WO2009064004A1 WO 2009064004 A1 WO2009064004 A1 WO 2009064004A1 JP 2008070842 W JP2008070842 W JP 2008070842W WO 2009064004 A1 WO2009064004 A1 WO 2009064004A1
Authority
WO
WIPO (PCT)
Prior art keywords
citrulline
drink
containing drink
develop
heated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/070842
Other languages
English (en)
French (fr)
Inventor
Yasushi Sakai
Takeshi Ikeda
Ayako Kamimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Hakko Bio Co Ltd
Original Assignee
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd
Priority to EP08850028.5A priority Critical patent/EP2215915B1/en
Priority to JP2009541200A priority patent/JP5944091B2/ja
Priority to CA2706556A priority patent/CA2706556A1/en
Priority to US12/743,172 priority patent/US8679568B2/en
Priority to CN200880116481.5A priority patent/CN101868156B/zh
Publication of WO2009064004A1 publication Critical patent/WO2009064004A1/ja
Anticipated expiration legal-status Critical
Priority to US14/175,698 priority patent/US9375479B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

　シトルリンを含有し、保存や加熱による悪臭の発生が抑制された飲みやすい飲料の開発が望まれている。 　本発明により、シトルリンおよびクエン酸と、クエン酸ナトリウムまたはリン酸水素ニナトリウムを含有する飲料が提供される。
PCT/JP2008/070842 2007-11-16 2008-11-17 シトルリン含有飲料 Ceased WO2009064004A1 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP08850028.5A EP2215915B1 (en) 2007-11-16 2008-11-17 Citrulline-containing beverage
JP2009541200A JP5944091B2 (ja) 2007-11-16 2008-11-17 シトルリン含有飲料
CA2706556A CA2706556A1 (en) 2007-11-16 2008-11-17 Citrulline-containing beverage
US12/743,172 US8679568B2 (en) 2007-11-16 2008-11-17 Citrulline-containing beverage
CN200880116481.5A CN101868156B (zh) 2007-11-16 2008-11-17 含瓜氨酸的饮料
US14/175,698 US9375479B2 (en) 2007-11-16 2014-02-07 Citrulline containing beverage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007297950 2007-11-16
JP2007-297950 2007-11-16

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/743,172 A-371-Of-International US8679568B2 (en) 2007-11-16 2008-11-17 Citrulline-containing beverage
US14/175,698 Continuation US9375479B2 (en) 2007-11-16 2014-02-07 Citrulline containing beverage

Publications (1)

Publication Number Publication Date
WO2009064004A1 true WO2009064004A1 (ja) 2009-05-22

Family

ID=40638849

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070842 Ceased WO2009064004A1 (ja) 2007-11-16 2008-11-17 シトルリン含有飲料

Country Status (7)

Country Link
US (2) US8679568B2 (ja)
EP (1) EP2215915B1 (ja)
JP (2) JP5944091B2 (ja)
KR (1) KR101547374B1 (ja)
CN (1) CN101868156B (ja)
CA (1) CA2706556A1 (ja)
WO (1) WO2009064004A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009171860A (ja) * 2008-01-22 2009-08-06 Asahi Soft Drinks Co Ltd シトルリン含有飲食品及びその製造方法
JP2017023073A (ja) * 2015-07-23 2017-02-02 テクノサイエンス株式会社 栄養補助食品用の組成物
KR20170033101A (ko) 2015-09-16 2017-03-24 원광대학교산학협력단 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물
JP2017140022A (ja) * 2016-02-10 2017-08-17 花王株式会社 容器詰飲料

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013102873A2 (en) * 2012-01-03 2013-07-11 Nestec S.A. Compositions and methods for the stability of reactive amino acids in a food matrix
US11102994B2 (en) * 2014-08-21 2021-08-31 Clearfast Inc. Pre-operative carbohydrate-rich beverage composition and methods of treatment

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6283882A (ja) * 1985-10-04 1987-04-17 Hitoshi Yoshida 高麗人じん酢の製造方法
JPH05246962A (ja) 1992-03-02 1993-09-24 Ajinomoto Co Inc 塩基性アミノ酸またはその塩を含む水溶液の防臭方法
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
JP2002226370A (ja) 2001-02-05 2002-08-14 Nara Institute Of Science & Technology シトルリンを含有する活性酸素消去剤
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
JP2007039610A (ja) * 2005-08-05 2007-02-15 Asahi Breweries Ltd レモンフレーバーの香気劣化抑制方法およびその飲料
JP2007185113A (ja) * 2006-01-11 2007-07-26 Seiya Sakurai コンニャク流動材料およびその製造方法と用途
JP2008073007A (ja) * 2006-09-25 2008-04-03 Kyowa Hakko Kogyo Co Ltd 酢かど抑制方法
WO2008105325A1 (ja) * 2007-02-23 2008-09-04 Kyowa Hakko Bio Co., Ltd. シトルリン含有飲料

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink
JPH0673446B2 (ja) * 1986-08-15 1994-09-21 長野県 西瓜ワインの製造法
US4946701A (en) * 1989-08-04 1990-08-07 Procter & Gamble Beverages
US6703056B2 (en) * 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
JP3329799B2 (ja) * 2000-11-17 2002-09-30 花王株式会社 容器詰飲料
JP2004173504A (ja) 2002-11-22 2004-06-24 Yakult Honsha Co Ltd 飲料の沈殿防止方法
JP4887499B2 (ja) 2004-04-30 2012-02-29 国立大学法人 奈良先端科学技術大学院大学 野生種スイカ抽出物を含有する活性酸素消去剤ならびに保湿剤
US7897192B2 (en) * 2004-10-07 2011-03-01 Next Proteins, Inc. High energy carbonated protein drink and method of making
JP4545632B2 (ja) 2005-04-25 2010-09-15 株式会社 伊藤園 葉酸含有組成物及び葉酸の安定化方法
EP1913943B1 (en) 2005-06-27 2011-09-21 Kyowa Hakko Bio Co., Ltd. Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria
WO2007023931A1 (ja) * 2005-08-25 2007-03-01 Kyowa Hakko Kogyo Co., Ltd. 血中アルコール濃度上昇抑制用組成物
US8153692B2 (en) 2005-12-05 2012-04-10 Kyowa Hakko Bio Co., Ltd. Oral preparation for preventing or improving skin dryness
JP2007274933A (ja) 2006-04-04 2007-10-25 Ito En Ltd ヒアルロン酸含有飲料及びその製造方法
US20070270355A1 (en) * 2006-05-11 2007-11-22 Garcia Ramon D Sport drink containing amino acids and carbohydrates

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6283882A (ja) * 1985-10-04 1987-04-17 Hitoshi Yoshida 高麗人じん酢の製造方法
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
JPH05246962A (ja) 1992-03-02 1993-09-24 Ajinomoto Co Inc 塩基性アミノ酸またはその塩を含む水溶液の防臭方法
JP2002226370A (ja) 2001-02-05 2002-08-14 Nara Institute Of Science & Technology シトルリンを含有する活性酸素消去剤
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
JP2007039610A (ja) * 2005-08-05 2007-02-15 Asahi Breweries Ltd レモンフレーバーの香気劣化抑制方法およびその飲料
JP2007185113A (ja) * 2006-01-11 2007-07-26 Seiya Sakurai コンニャク流動材料およびその製造方法と用途
JP2008073007A (ja) * 2006-09-25 2008-04-03 Kyowa Hakko Kogyo Co Ltd 酢かど抑制方法
WO2008105325A1 (ja) * 2007-02-23 2008-09-04 Kyowa Hakko Bio Co., Ltd. シトルリン含有飲料

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CELL BIOCHEMISTRY & FUNCTION, vol. 21, 2003, pages 85 - 91
EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 431, 2001, pages 61 - 69
GASTROENTEROLOGY, vol. 112, 1997, pages 1250 - 1259
J. BIOL. CHEM., vol. 122, 1938, pages 477
J. ORG. CHEM., vol. 6, 1941, pages 410
JOURNAL OF CLINICAL INVESTIGATION, vol. 88, 1991, pages 1559 - 1567
THE JOURNAL OB BIOLOGICAL CHEMISTRY, vol. 269, 1994, pages 9405 - 9408

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009171860A (ja) * 2008-01-22 2009-08-06 Asahi Soft Drinks Co Ltd シトルリン含有飲食品及びその製造方法
JP2017023073A (ja) * 2015-07-23 2017-02-02 テクノサイエンス株式会社 栄養補助食品用の組成物
KR20170033101A (ko) 2015-09-16 2017-03-24 원광대학교산학협력단 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물
JP2017140022A (ja) * 2016-02-10 2017-08-17 花王株式会社 容器詰飲料

Also Published As

Publication number Publication date
CN101868156B (zh) 2014-03-12
JP2014236743A (ja) 2014-12-18
US8679568B2 (en) 2014-03-25
JP5955358B2 (ja) 2016-07-20
CA2706556A1 (en) 2009-05-22
JP5944091B2 (ja) 2016-07-05
US20140179783A1 (en) 2014-06-26
EP2215915A1 (en) 2010-08-11
EP2215915A4 (en) 2014-10-15
US9375479B2 (en) 2016-06-28
KR20100100878A (ko) 2010-09-15
JPWO2009064004A1 (ja) 2011-03-31
US20100255174A1 (en) 2010-10-07
CN101868156A (zh) 2010-10-20
EP2215915B1 (en) 2017-04-05
KR101547374B1 (ko) 2015-08-25

Similar Documents

Publication Publication Date Title
WO2009064004A1 (ja) シトルリン含有飲料
IL197207A0 (en) Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
EP1888728A4 (en) Fatty acid analogues, D.H. DHA DERIVATIVES FOR USE AS A MEDICAMENT
WO2010060581A3 (de) Herbizid-safener-kombination
MX2011006519A (es) Liberacion sostenida de nutrientes in vivo.
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
AU315061S (en) Shoe sole
WO2007115305A3 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
WO2007057203A3 (de) Geruchsbindende superabsorbierende zusammensetzung
WO2008022974A3 (fr) Composition antidiabetique contenant de l'acide chicorique et/ou l'un de ses metabolites
GB0514463D0 (en) Use of pinolenic acid
WO2010091154A3 (en) Compositions and methods for joining non-conjoined lumens
WO2008033499A3 (en) Modulation of regulatory t cells by human il-18
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
MX2007003196A (es) Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
EP1882631A4 (en) AQUEOUS SOLUTION OF HYDROGEN PEROXIDE FOR STERILIZATION
WO2007013901A3 (en) Color-stabilization of aromachemicals
WO2007109174A3 (en) Compositions and methods for modulation of mcl-1 expression
Wei et al. Existence and uniqueness of global solutions for a mathematical model of antiangiogenesis in tumor growth
DK1880727T3 (da) Topisk vaginal farmaceutiske sammensætninger
AR048167A1 (es) Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio
WO2009079401A3 (en) Compositions and methods for increasing iron absorption
WO2008120766A1 (ja) 鎮痛用組成物
WO2009054483A1 (ja) サリューシン-βを含む医薬
WO2008060441A3 (en) Stable amifostine liquid concentrate

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880116481.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08850028

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009541200

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12743172

Country of ref document: US

Ref document number: 2706556

Country of ref document: CA

Ref document number: 12010501097

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008850028

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008850028

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107013197

Country of ref document: KR

Kind code of ref document: A